Newark, New Castle, USA, June 09, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global was conducted by Growth Plus Reports in 2022 and valued at US$ 816.10 million. The market is expected to hit a revenue CAGR of 6.3% to reach US$ 1,498.24 million by 2031.
Millions of individuals throughout the world are impacted by chronic hepatitis B virus (HBV) infection, which is a serious public health issue. For early identification, illness progression monitoring, and directing suitable treatment measures, timely and reliable HBV testing is essential. Due to the increased incidence of the virus, a growing understanding of the value of testing, and improvements in diagnostic techniques, the market for chronic HBV testing has experienced tremendous expansion.
Request a Free Sample of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/chronic-hepatitis-b-virus-testing-market/8874
Chronic Hepatitis B Virus Testing Market Scope
| Report Attribute | Details |
| Market Size Value in 2022 | US$ 816.10 million |
| Revenue Forecast in 2031 | US$ 1,498.24 million |
| CAGR | 6.3% |
| Base Year for Estimation | 2022 |
| Forecast Period | 2023 to 2031 |
| Historical Year | 2021 |
| Segments Covered | Product type, End user, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
The development of point-of-care testing for chronic HBV is one of the study's main conclusions. Point-of-care tests provide quick and practical diagnostic solutions that may be carried out in low-resource situations or at the patient's bedside. By facilitating early antiviral medication initiation, improving patient management, and enabling fast diagnosis, these diagnostics help to lessen the burden of chronic HBV infection.
The study also emphasizes the significance of thorough testing methods and HBV screening programs. The importance of extensive testing, particularly in high-risk groups, is being emphasized more and more by public health organizations and healthcare systems to find undetected cases, stop transmission, and offer the proper care and treatment. To conduct successful testing programs, the paper underlines the importance of cooperation between healthcare providers, decision-makers, and advocacy organizations.
Recent Development in the Chronic Hepatitis B Virus Testing Market:
- Prior to World Hepatitis Day (July 28), WHO urged nations to scale up their efforts to eradicate illness by utilizing recent decreases in the cost of identifying and treating viral hepatitis.
Competitive Landscape
A list of the key market players operating in the global market for chronic hepatitis B virus testing includes:
- DiaSorin S.p.A.
- Abbott Laboratories
- Vista Diagnostics International
- Meridian Biosciences
- Siemens Medical Solutions USA, Inc.
Market Segmentation:
-
- Based on Product Type, the global Chronic Hepatitis B Virus Testing Market is segmented into Enzyme Immunoassay Kits, Hepatitis B Surface Antigen Tests, Anti-Hepatitis B Surface Antibody Tests, Anti-Hepatitis B Core Antibody Tests, and Point-of-Care Testing Kits.
- Enzyme Immunoassay (EIA) kits are commonly used for chronic hepatitis B virus testing and are regarded as a reliable and accurate method of identifying HBV infection.
- Based on End User, the global Chronic Hepatitis B Virus Testing Market is segmented into Hospitals, Clinics, Diagnostics Centers, and Home Care.
Report Coverage
Growth Plus Reports conducted extensive global market research for testing for chronic hepatitis B virus. We examined the fundamental characteristics of the market, notable investment opportunities, regional development patterns, ten-year revenue estimates, competing market actors, and mergers and acquisitions.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- Regulatory Landscape
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL CHRONIC HEPATITIS B VIRUS TESTING MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE
- Enzyme Immunoassay Kits
- Hepatitis B Surface Antigen Test
- Anti-Hepatitis B Surface Antibody Test
- Anti-Hepatitis B Core Antibody Test
- Point-of-Care Testing Kits
- GLOBAL CHRONIC HEPATITIS B VIRUS TESTING MARKET - ANALYSIS & FORECAST, BY END USER
- Hospitals
- Clinics
- Diagnostics Centers
- Home Care
CHRONIC HEPATITIS B VIRUS TESTING MARKET TOC
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8874
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at - https://www.growthplusreports.com/report-store
Browse more latest healthcare reports:
Hypertensive Crisis Agents Market by Drug Class (Beta-blockers, Vasodilators, Calcium Channel Blockers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Nummular Eczema Treatment Market by Drug Class (Immunomodulators, Antibiotics, Antihistamines), Route of Administration (Topical, Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Global Outlook & Forecast 2023-2031
Gastric Function Test Market by Test Type (Helicobacter Pylori Tests, Gastric Motility Tests, Gastric Emptying Tests), Application (Gastric Cancer, Gastroesophageal Reflux Disease (GERD), Gastroparesis), End User (Hospitals, Diagnostic Laboratories) – Global Outlook & Forecast 2023-2031
Adenosine Deaminase Inhibitors Market by Type (Pentostatin, Elapegademase), Application (Chronic Lymphocytic Leukemia, Hairy Cell Leukemia) – Global Outlook & Forecast 2023-2031
Adenosquamous Carcinoma Treatment Market by Indication (Breast Cancer, Lungs Cancer), Treatment Regime (Monotherapy, Combination Therapy), Therapy (Chemotherapy, Immunotherapy) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
